×
About 1,628 results

ALLMedicine™ Hirsutism Center

Research & Reviews  529 results

Yolk Sac Tumor of the Ovary: A Report of 150 Cases and Review of the Literature.
https://doi.org/10.1097/PAS.0000000000001793
The American Journal of Surgical Pathology; Young RH, Wong A et. al.

Sep 2nd, 2021 - One hundred fifty yolk sac tumors (YSTs) of the ovary in patients from 1 to 61 (mean: 21.5) years of age are described; 75% of the patients were in the second and third decades and only 1 was above 50 years of age. The clinical manifestations were...

Ovarian Leydig Cell Tumor: Cause of Virilization in a Postmenopausal Woman.
https://doi.org/10.12659/AJCR.933126
The American Journal of Case Reports; Mourinho Bala N, Aragüés JM et. al.

Aug 28th, 2021 - BACKGROUND Only 0.5% of all ovarian tumors are Leydig cell tumors and they are generally benign and unilateral. These androgen-secreting tumors lead to virilizing symptoms, most often in postmenopausal women. Because Leydig cell tumors are typical...

Management of Fully Pubertal Girls With Nonclassical Congenital Adrenal Hyperplasia: Gl...
https://doi.org/10.1016/j.eprac.2021.08.005
Endocrine Practice : Official Journal of the American Col... de Vries L, Baum M et. al.

Aug 27th, 2021 - To compare clinical outcomes of 3 treatment regimens-glucocorticoids (GCs), oral contraceptives (OCs), or a combination of both-administered to adolescents and young women diagnosed in childhood with nonclassical congenital adrenal hyperplasia (NC...

Depression and anxiety in women with polycystic ovarian syndrome: a literature survey.
https://doi.org/10.1515/ijamh-2021-0092
International Journal of Adolescent Medicine and Health; Zehravi M, Maqbool M et. al.

Aug 23rd, 2021 - Polycystic ovarian syndrome (PCOS) is the most frequent endocrine disorder among women of reproductive age. Some of the indications and symptoms of PCOS include amenorrhoea, hirsutism, infertility, obesity, acne vulgaris and androgenic alopecia. P...

Hirsutism and Menstrual Irregularity in a 16-year-old Girl.
https://doi.org/10.1542/pir.2020-002089
Pediatrics in Review; Bruggeman BS, Bernier A

Aug 4th, 2021 - Hirsutism and Menstrual Irregularity in a 16-year-old Girl.|2021|Bruggeman BS,Bernier A,|

see more →

Guidelines  3 results

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clin...
https://doi.org/10.1210/jc.2018-00241
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Anderson RR et. al.

Mar 10th, 2018 - To update the "Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline," published by the Endocrine Society in 2008. The participants include an Endocrine Society-appointed task force of seven...

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Andro...
https://doi.org/10.1093/humupd/dmr042
Human Reproduction Update; Escobar-Morreale HF, Carmina E et. al.

Nov 9th, 2011 - Hirsutism, defined by the presence of excessive terminal hair in androgen-sensitive areas of the female body, is one of the most common disorders in women during reproductive age. We conducted a systematic review and critical assessment of the ava...

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clin...
https://doi.org/10.1210/jc.2007-2437
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Chang RJ et. al.

Feb 7th, 2008 - Our objective was to develop clinical practice guidelines for the evaluation and treatment of hirsutism in premenopausal women. The Task Force was composed of a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society...

see more →

Drugs  28 results see all →

Clinicaltrials.gov  2 results

Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)
https://clinicaltrials.gov/ct2/show/NCT04355572

Apr 26th, 2021 - Patients referred to the pediatric endocrinology clinic or adolescent gynecology clinic at Yale New Haven Children Hospital with a primary complaint of hirsutism, acne, or amenorrhea and/or oligomenorrhea persisting 2 years after their menarche wi...

Database Study on Patients With PCOS
https://clinicaltrials.gov/ct2/show/NCT01338519

Apr 19th, 2011 - All premenopausal women referred to the outpatient clinic at the Department of Endocrinology from 1997 and onward with the referral diagnoses hirsutism and/or PCOS are included in a clinical database. The patients should fulfill the Rotterdam crit...

see more →

News  86 results

Increased Risk of Meningioma With Cyproterone Acetate Use
https://www.medscape.com/viewarticle/945218

Feb 3rd, 2021 - New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen and potent anti-androgen that has been used in the treatme...

Metformin Not Better Than Oral Contraceptive for Treating PCOS-Related Hirsutism
https://www.medscape.com/viewarticle/936850

Sep 8th, 2020 - NEW YORK (Reuters Health) - Metformin monotherapy might be less effective than oral contraceptive pills (OCPs) for treating hirsutism in women with polycystic ovary syndrome (PCOS), according to a new Cochrane review. In fact, "OCP alone or metfor...

Study finds spironolactone doesn’t boost breast cancer recurrence
https://www.mdedge.com/jcomjournal/article/219611/hair-nails/study-finds-spironolactone-doesnt-boost-breast-cancer?channel=39313
Bruce Jancin

Mar 25th, 2020 - Spironolactone for the treatment of endocrine therapy–induced alopecia in breast cancer survivors was not associated with increased risk of recurrence of the malignancy in a large retrospective study, Chapman Wei said in a in a virtual meeting hel.

GPs Need Better Education on All Symptoms of PCOS, Say Patients
https://www.medscape.com/viewarticle/927116

Mar 19th, 2020 - Women who have polycystic ovary syndrome (PCOS) often feel their general practitioners (GPs) trivialize the condition as only a fertility problem and do not discuss any of the other long-term health consequences, new results from a UK survey revea...

EU Restricts High-Dose Cyproterone Because of Meningioma Risk
https://www.medscape.com/viewarticle/925271

Feb 14th, 2020 - Cyproterone products with daily doses of 10 mg or more should be restricted because of a risk of developing meningioma, says the safety committee of the European Medicines Agency. Products containing cyproterone 10 mg daily or more should be used ...

see more →

Patient Education  3 results see all →